Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2020
Enrollment ongoing in Phase 1 dose-escalation trial BALLI-01 in r/r B-ALL patientsEnrollment ongoing in Phase 1 dose-escalation trial AMELI-01 in […]